论文部分内容阅读
目的:研究小儿病毒性脑炎的临床表现的治疗方式。方法:选取2013年5月~2014年7月间我院儿科收治的病毒性脑炎患儿80例,随机将其分成观察组42例与对照组38例,观察组患儿采用更昔洛韦治疗,对照组患儿采用病毒唑治疗,观察比较两组患儿治疗后的在不同方法治疗后的临床疗效。结果:观察组患儿与对照组患儿的发热症状消失时间无显著差异,P>0.05。对照组患儿的呕吐消失时间、头痛消失时间、抽搐消失时间均明显长于观察组患儿,差异显著,有统计学意义,P<0.05。观察组出现患儿的意识障碍、发热、呕吐、头痛、抽搐人数与对照组患儿相比,差异无统计学意义,P>0.05。结论:小儿病毒性脑炎采用更昔洛韦治疗的临床疗效显著,且安全性高,不良反应小,有效的提高了患儿的生存质量,值得临床应用。
Objective: To study the treatment of clinical manifestations of viral encephalitis in children. Methods: Eighty children with viral encephalitis admitted to our hospital from May 2013 to July 2014 were randomly divided into observation group (42 cases) and control group (38 cases). Patients in observation group were treated with ganciclovir The patients in the control group were treated with ribavirin, and the clinical efficacy of different treatments after treatment in both groups was observed and compared. Results: There was no significant difference in the disappearance of fever between children in the observation group and control group (P> 0.05). The vomiting disappearance time, headache disappearing time and convulsions disappearing time in the control group were significantly longer than those in the observation group, with significant difference (P <0.05). There was no significant difference in the observation group between children with unconsciousness, fever, vomiting, headache and convulsions compared with those in the control group (P> 0.05). CONCLUSION: The clinical efficacy of ganciclovir in treatment of pediatric viral encephalitis is significant, and its safety and adverse reactions are small, which effectively improves the quality of life of children and deserves clinical application.